Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Creative Style: 10 Architects Reclassifying the Business - 2Weight-loss pill approval set to accelerate food industry product overhauls
- 3Russia patents space station designed to generate artificial gravity
- 4Building a Maintainable Closet: Individual Excursions in Moral Style
- 5PFAS in pregnant women’s drinking water puts their babies at higher risk, study finds
- Track down Your Optimal Conservative Vehicle: Famous Brands to Consider
- 5 Critical Rules For Business Regulation Chiefs
- Netanyahu expects Iran's leadership to fall
- It May Take a Year to Restore Abu Dhabi Aluminum Output, EGA Says
- Atorvastatin recall may affect hundreds of thousands of patients – and reflects FDA’s troubles inspecting medicines manufactured overseas
- Extraordinary Picks for Home Apparatuses: Making Life Simpler
- The Red Sea strategy: What does Israel stand to gain from recognizing Somaliland?
- Tatiana Schlossberg, a granddaughter of JFK, is dead at 35 after cancer diagnosis
- 5 Pizza Fixings That Characterize Your Character
